共 98 条
[1]
Feinstein A.R., On white-coat effects and the electronic monitoring of compliance, Arch Intern Med, 150, pp. 1377-8, (1990)
[2]
Agras W.S., Understanding compliance with the medical regimen: the scope of the problem and a theoretical perspective, Arthritis Care & Research, 2, pp. S2-S7, (1989)
[3]
Haynes R.B., Introduction, Compliance in Health Care, pp. 1-7, (1979)
[4]
Steiner J.F., Fihn S.D., Blair B., Inui T.S., Appropriate reductions in compliance among well-controlled hypertensive patients, J Clin Epidemiol, 44, pp. 1361-71, (1991)
[5]
Sackett D.L., A compliance practicum for the busy practitioner, Compliance in Health Care, (1979)
[6]
Meichenbaum D., Turk D.C., Facilitating Treatment Adherence: A Practitioner’s Guidebook, pp. 44-5, (1987)
[7]
Haynes R.B., Dantes R., Patient compliance and the conduct and interpretation of therapeutic trials, Controlled Clin Trials, 8, pp. 12-9, (1987)
[8]
Goldsmith C.H., The effect of compliance distributions on therapeutic trials, Compliance in Health Care, pp. 297-308, (1979)
[9]
Lang J.M., Buring J.E., Rosner B., Cook N., Hennekens C.H., Estimating the effect of the run-in on the power of the Physicians’ Health Study, Stat Med, 10, pp. 1585-93, (1991)
[10]
Maenpaa H., Manninen V., Heinonen O.P., Compliance with medication in the Helsinki Heart Study, Eur J Clin Pharmacol, 42, pp. 15-9, (1992)